BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32663453)

  • 1. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
    Schönthal AH; Swenson SD; Chen TC; Markland FS
    Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Snake venom disintegrins: classification and therapeutic potential].
    Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
    Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disintegrins.
    McLane MA; Sanchez EE; Wong A; Paquette-Straub C; Perez JC
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):327-55. PubMed ID: 15578957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
    Swenson S; Costa F; Ernst W; Fujii G; Markland FS
    Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disintegrins from snake venoms and their applications in cancer research and therapy.
    Arruda Macêdo JK; Fox JW; de Souza Castro M
    Curr Protein Pept Sci; 2015; 16(6):532-48. PubMed ID: 26031306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights of snake venom disintegrins in cancer treatment.
    Akhtar B; Muhammad F; Sharif A; Anwar MI
    Eur J Pharmacol; 2021 May; 899():174022. PubMed ID: 33727054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
    Kuo YJ; Chung CH; Huang TF
    Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function correlations of snake venom disintegrins.
    Calvete JJ
    Curr Pharm Des; 2005; 11(7):829-35. PubMed ID: 15777237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
    Mercer B; Markland F; Minkin C
    J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenesis and RGD-containing snake venom disintegrins.
    Swenson S; Ramu S; Markland FS
    Curr Pharm Des; 2007; 13(28):2860-71. PubMed ID: 17979731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.
    Minea R; Helchowski C; Rubino B; Brodmann K; Swenson S; Markland F
    Toxicon; 2012 Mar; 59(4):472-86. PubMed ID: 21354198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The continuing saga of snake venom disintegrins.
    Calvete JJ
    Toxicon; 2013 Feb; 62():40-9. PubMed ID: 23010163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.
    Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC
    Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
    Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
    Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
    Marcinkiewicz C
    Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of snake venom components to modulate integrin activities in cell-matrix interactions.
    Marcinkiewicz C
    Int J Biochem Cell Biol; 2013 Sep; 45(9):1974-86. PubMed ID: 23811033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential use of snake venom components in cancer treatment].
    Vivas D; Inga R; Yarlequé A
    Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
    Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
    Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.
    Swenson S; Minea RO; Tuan CD; Thein TZ; Chen TC; Markland FS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom.
    Zhou Q; Hu P; Ritter MR; Swenson SD; Argounova S; Epstein AL; Markland FS
    Arch Biochem Biophys; 2000 Mar; 375(2):278-88. PubMed ID: 10700384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.